Peer Review History
| Original SubmissionJune 28, 2021 |
|---|
|
PONE-D-21-21158 Phylogenetic analyses of Norwegian Tenacibaculum strains confirm high bacterial diversity and suggest circulation of ubiquitous virulent strains PLOS ONE Dear Dr. Lagadec, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please see my comments below. Please submit your revised manuscript by Sep 25 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Lloyd Vaughan, PhD, BSc (Hons) Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 3. We note that Figure 2 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: a) You may seek permission from the original copyright holder of Figure 2 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” b) If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ Additional Editor Comments: Dear Dr. Lagadec, Thankyou for submitting this interesting manuscript to PloSOne. As you can see from the reviewers' comments, they are all in favour of publishing your findings, as I am as well, but have reservations which would need to first be addressed. These are all experienced fish pathologists whose opinions I value highly and I was especially happy that they all consented to review your manuscript. That they did so is no doubt also a reflection of your own work and that of your group. I very much agree with their suggestions and recommendations and am convinced that by addressing the points they have raised that this will improve your manuscript, and inevitably counter any likely queries which would have been raised by a critical readership. The diversity in Tenacibaculum strains you and your colleagues have discovered in Norwegian waters is truly impressive and I have no doubt that groups in other parts of the world will be stimulated by your findings to explore their own regions in greater detail. This will be key to developing vaccines which can be widely applied to countering this threat to aquaculture and the ensuing consequences on the environment. In this context, the additional details and information sought by the reviewers will be invaluable for those planning such studies. I am very much looking forward to your response to these suggestions, just as much as I enjoyed reading the manuscript you sent in. Kind regards, Lloyd Vaughan [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly Reviewer #3: Yes Reviewer #4: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: N/A Reviewer #4: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: To better understanding the pathogen diversity underlying fish diseases is an important prerequisite for the control of the disease. The submitted Ms aims to examine the diversity of Tenacibaculum spp. Bacteria in Norwegian aquaculture. These bacteria are opportunistic pathogens and can cause ulcerative diseases. While originally, focus was T. maritimum , more recent research unraveled that there is much more diversity of Tenacibaculum species in aquaculture. The present study further extends the knowledge on the diversity of this genus, and as such it is of relevance. Methodologically, the authors collected bacteria from marine fish farms suffering outbreaks of ulcerative skin disease during 2017-2019. The bacteria were isolated from diseased tissues, were cultured and then the 16S rRNA was sequenced using MLST. Personally, I am not an expert on MLST and thus are not in a position to judge on the adequacy of the molecular methodology. However, I have several questions on the sampling methodology: how many fish were sampled per farm? Were only diseased or also healthy fish/tissues sampled? Were all isolates from one fish pooled, were isolates from different individuals pooled, or were all isolates treated separately? Were only Tenacibuculum bacteria analysed or was a broader microbial characterization of the diseased fish performed? In particular I would be interested to know what evidence can be provided by the authors that the Tenacibaculum bacteria are indeed causative to the ulcerative changes. The mere presence of a bacterial species on a diseased fish dos not necessarily mean that this species is the etiological agent. Results: The data based in figure 1 are based on the analysis of 7 loci – what criteria were used to select those 7 loci? Line 163: Since sampling details are inadequately described (see above), it is difficult to follow the results. For instance, in line 165 its says that ST-160 was isolated form both the skin ulcer and the head kidney of the same fish. Was ST-160 found in other tissues of this fish as well, or were other tissues not analysed? And was this fish the only fish with ST-160 in the farm/the only fish with ulcer, or were more fish positive for ST-160, and did they all show skin ulcer? This is a lot of detail, but this detail is critical to understand the association of T. spp with ulcer. In addition, while the Results provide an in-depth MLST analysis, I missed an "epidemiological" analysis: For instance, the authors investigated a range of fish species: were certain strains/ST associated with certain host species or was no pattern detectable? Was there an association between farm conditions, ulcer prevalence/severity and presence of specific strains? If this study should go beyond a mere analysis of genetic diversity but would like to promote understanding of the disease epidemiology, more emphasis on this type of questions is required. In the way as presented now, the ms unfortunately does not provide insight how the results of this study would support "future epidemic management" (line 64) The concluding sentence of the abstract says: "Understanding their reservoirs and transmission pathways could help to address major challenges in connection with prophylactic measures and development of vaccines". I fully agree with this statement, but I do not see how this Ms as presented now would support these aims. Interestingly, the authors address these questions in the Discussion, but unfortunately they do not apply it to their own study. Reviewer #2: Phylogenetic analyses of Norwegian Tenacibaculum strains confirm high bacterial diversity and suggest circulation of ubiquitous virulent strains, by Lagadec et al. In this manuscript, the authors provide useful information about the diversity of Tenacibaculum spp. in the Norwegian fish farms. Bacteria belonging to the Tenacibaculum genus have become important opportunistic pathogens for many different marine fishes and lately have been associated with ulcerative diseases in farmed salmon. The authors have collected several strains from different regions in Norway and have used MLST analysis to map their genetic diversity. Although the manuscript is well-written, and the information provided is useful there are some important points that should be considered. It seems to me that the strains used in the study have been collected by fish vets during routine diagnostic analyses and are not part of a specific research survey of the team. This if fully acceptable and understandable, however if this is true, it should be specifically mentioned in the manuscript. I am not very sure if the media used in the isolation would favor the growth of all possible Tenacibaculum spp. These bacteria are difficult to isolate, and in many cases, there is overgrowth by other faster growing opportunistic bacteria. The use of general isolation media may have hindered the growth of other species like Tenacibaculum maritimum. Furthermore, I am not convinced that the heamolytic activity of Tenacibaculum strains is a valid indicator of pathogenicity. There are several non-haemolytic bacterial pathogens which are highly virulent. Although the authors state that the occurrence of beta haemolysis is an indicator of pathogenicity (supported by a relevant citation), the non-occurrence does not mean that the strains are less virulent. Haemolytic activity has been used extensively by the authors, however how it was assessed is not described in the M&M. More care should be given in the use of haemolysis as virulence factor for Tenacibaculum in order to be convincing. Specific comments to the authors: L53: move (MA) after Marine Agar L53: Explain how the use of MA associates Tenacibaculum with winter ulcers L68: Mention how many samples were used L75-78: Are these the best media for isolating Tenacibaculum spp? What about FMA or TMA? It seems that these media are mostly used for routine microbiology by the fish vets. If this is the case, it should be stated either in the M&M or in the introduction, since this is a limitation of the study that may have biased the results. If this is not the case, then you should provide references supporting the use of these media for the specific isolation of Tenacibaculum spp. L:78 It is not clear later in the results how many of the isolates were Tenacibaculum. If there were other bacteria present, which were these? What is the prevalence of Tenacibaculum during the outbreaks? L80: What are the characteristics of the colonies? are these the same in all media? were they described also in Blood Agar? In the papers cited the authors have used different media. L82: Describe the morphology L143: Table legend: You talk about haemolytic activity but how this was assessed is not in the M&M. Since haemolytic capacity of the bacteria plays an important role in your paper, the method used to assess it should be described L190-191: How do you define “variable”? Have you used replicates in the heamolytic activity assay? L266: What are the severe symptoms? Where were they described? L276: How did you come to this conclusion that the non-haemolytic strains are less pathogenic? If the conclusion is based on the field data (eg morbidity/mortality), these data should be provided. Even then, the conclusion is really based on circumstantial evidence, and it is indicative if not speculative. Unless there are comparative data from challenge tests (if yes, then you should provide these data). L281: The association of hemolysis to virulence or to be more accurate, the non-hemolysis to non- or reduced virulence is not supported by evidence and it is speculative. Reviewer #3: This manuscript provides additional information on the epidemiology of Tenacibaculosis and should be published. The information provided is sound and useful but not a significantly novel contribution to fish bacteriology, but should be published as it provides good information on the distribution and epidemiology of the bacterial isolates of concern. Reviewer #4: The manuscript submitted by Lagadec et al (PONE-D-21-21158) is a well presented and informative paper showing the diversity that exists amongst Tenacibaculum spp. strains in Norwegian aquaculture. I have a few minor points for the authors to address. Line 39 - bacterial diseases Line 44 - Tenacibaculosis has been reported in marine wild and farmed fish in Europe, Asia, Line 52 - Due to the increased use of Marine Agar (MA) for bacterial isolation in recent years, Tenacibaculum spp. have also been associated with the winter ulcer disease, previously attributed to the bacterium Moritella viscosa [25, 26]. Line 89 - 10,000 rpm – state xg rather than rpm Lines 139/194/213/294 - Numbers at the start of sentences should be written in words rather than as a number. Line 151- March 2019 Line 161 - Of the 27 new STs, 22 were isolated during a single outbreak of tenacibaculosis. Was the outbreak at a single site - mention the location of this outbreak? Line 278 - Overall, non-haemolytic Tenacibaculum strains seem to be less pathogenic and may not lead to tenacibaculosis outbreaks. Can you state the evidence for this e.g. a reference or findings from your study? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #3: No Reviewer #4: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Phylogenetic analyses of Norwegian Tenacibaculum strains confirm high bacterial diversity and suggest circulation of ubiquitous virulent strains PONE-D-21-21158R1 Dear Dr. Lagadec, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Lloyd Vaughan, PhD, BSc (Hons) Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-21158R1 Phylogenetic analyses of Norwegian Tenacibaculum strains confirm high bacterial diversity and suggest circulation of ubiquitous virulent strains. Dear Dr. Lagadec: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Dr. Lloyd Vaughan Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .